Mingzhao Xing

Medicine & Life Sciences

1. Thyroid Neoplasms 100%
2. Papillary Thyroid Cancer 97%
3. Mutation 65%
4. Thyroid Gland 35%
5. Methylation 25%
6. Neoplasms 24%
7. Anaplastic Thyroid Carcinoma 22%
8. Madin Darby Canine Kidney Cells 21%
9. Mitogen-Activated Protein Kinase Kinases 19%
10. Genes 19%
11. Arachidonic Acid 17%
12. Phosphatidylinositol 3-Kinase 16%
13. Cytosolic Phospholipases A2 14%
14. Telomerase 14%
15. Tumor Suppressor Genes 13%
16. Phospholipases A2 13%
17. Thyroid Nodule 13%
18. Phosphotransferases 12%
19. Carcinogenesis 12%
20. Protein Kinase C 11%
21. AZD 6244 9%
22. Proto-Oncogene Proteins B-raf 9%
23. Neoplasm Metastasis 9%
24. Lymph Nodes 9%
25. Mitogen-Activated Protein Kinases 8%
26. Melanoma 8%
27. Papillary Thyroid Microcarcinoma 8%
28. Epigenomics 8%
29. Recurrence 8%
30. Cell Line 8%
31. Purinergic Receptors 7%
32. Mortality 7%
33. Iodine 7%
34. Purinergic P2Y2 Receptors 7%
35. Phosphatidylinositol 3-Kinases 7%
36. Vemurafenib 6%
37. Fine Needle Biopsy 6%
38. Elasticity Imaging Techniques 6%
39. Gene Expression 6%
40. TOR Serine-Threonine Kinases 6%
41. Adenosine Triphosphate 5%
42. MK 2206 5%
43. Therapeutics 5%
44. perifosine 5%
45. sodium-iodide symporter 5%
46. Acoustics 5%
47. Iodides 5%
48. N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 5%